Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
Provided By GlobeNewswire
Last update: May 12, 2025
Announced Boehringer Ingelheim strategic collaboration and license agreement for CUE-501, including an upfront payment of $12 million and ~$345 million in potential milestone payments
Read more at globenewswire.comNASDAQ:CUE (7/3/2025, 10:36:57 AM)
0.6999
+0.01 (+1.14%)
Find more stocks in the Stock Screener
CUE Latest News and Analysis
2 days ago - ChartmillWhat's going on in today's after hours sessionLet's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
